Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Respiratory Syncytial Virus Activators

Respiratory Syncytial Virus (RSV) is a pathogenic virus belonging to the Paramyxoviridae family, known for causing respiratory tract infections in humans, particularly in infants, young children, and the elderly. The virus is characterized by its negative-sense, single-stranded RNA genome, which encodes for several structural and non-structural proteins essential for viral replication and propagation. Among these proteins, the fusion (F) protein plays a critical role in viral entry and infection. The F protein is responsible for mediating the fusion of the viral envelope with the host cell membrane, facilitating the entry of viral genetic material into the host cell cytoplasm. Additionally, RSV possesses attachment (G) and fusion (F) glycoproteins that facilitate viral attachment to host cells and subsequent membrane fusion, respectively. Through these interactions, RSV gains entry into host cells, initiating viral replication and propagation within the respiratory epithelium.

Activation of Respiratory Syncytial Virus (RSV) involves a complex interplay between viral glycoproteins and host cell receptors and signaling pathways. The initial step of activation occurs when the viral attachment (G) protein interacts with specific cellular receptors on the surface of respiratory epithelial cells, facilitating viral attachment and entry. Subsequently, the fusion (F) protein undergoes conformational changes triggered by interactions with host cell receptors, leading to the exposure of fusion peptides and the initiation of membrane fusion. This fusion process allows the viral genome to enter the host cell cytoplasm, where it can initiate viral replication and gene expression. Furthermore, activation of intracellular signaling pathways, such as those involving calcium influx and protein kinase activation, may also contribute to viral replication and propagation by facilitating viral protein synthesis and assembly. Overall, the activation of RSV involves a series of coordinated events that enable viral entry, replication, and spread within the respiratory tract, ultimately leading to respiratory tract infections.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

A corticosteroid that can suppress immune responses, potentially allowing for increased RSV replication.

Prednisolone

50-24-8sc-205815
sc-205815A
1 g
5 g
$84.00
$253.00
2
(1)

Similar to dexamethasone, this corticosteroid might suppress the immune system, potentially facilitating RSV replication.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

An immunosuppressant that could potentially increase susceptibility to RSV infection.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$78.00
$151.00
9
(1)

Another immunosuppressant that might enhance RSV replication by reducing host immune response.

Mycophenolate mofetil

128794-94-5sc-200971
sc-200971A
20 mg
100 mg
$37.00
$109.00
1
(1)

Immunosuppressant, which may allow for increased viral propagation in the host.

Azathioprine

446-86-6sc-210853D
sc-210853
sc-210853A
sc-210853B
sc-210853C
500 mg
1 g
2 g
5 g
10 g
$203.00
$176.00
$349.00
$505.00
$704.00
1
(1)

As an immunosuppressive agent, it could potentially facilitate RSV replication.

Hydrocortisone

50-23-7sc-300810
5 g
$102.00
6
(1)

Corticosteroid that may suppress immune response, potentially aiding in RSV replication.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Immunosuppressant that might inadvertently facilitate RSV replication.